101 related articles for article (PubMed ID: 8069014)
1. Efficacy and adverse effects of transpulmonary contrast echocardiography using sonicated albumin.
Nakatani S; Beppu S; Ohta T; Matsuda H; Miyatake K
Intern Med; 1994 Apr; 33(4):204-9. PubMed ID: 8069014
[TBL] [Abstract][Full Text] [Related]
2. Myocardial contrast echocardiography without significant hemodynamic effects or reactive hyperemia: a major advantage in the imaging of regional myocardial perfusion.
Keller MW; Glasheen W; Teja K; Gear A; Kaul S
J Am Coll Cardiol; 1988 Oct; 12(4):1039-47. PubMed ID: 3417978
[TBL] [Abstract][Full Text] [Related]
3. Successful left ventricular opacification following peripheral venous injection of sonicated contrast agent: an experimental evaluation.
Keller MW; Feinstein SB; Watson DD
Am Heart J; 1987 Sep; 114(3):570-5. PubMed ID: 3307360
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
[TBL] [Abstract][Full Text] [Related]
5. The influence of intravenous Albunex injections on pulmonary arterial pressure, gas exchange, and left ventricular peak intensity.
Walker R; Wiencek JG; Aronson S; Zaroff J; Glock D; Thisted R; Feinstein SB
J Am Soc Echocardiogr; 1992; 5(5):463-70. PubMed ID: 1389214
[TBL] [Abstract][Full Text] [Related]
6. Intravenous contrast echocardiography with use of sonicated albumin in humans: systolic disappearance of left ventricular contrast after transpulmonary transmission.
Shapiro JR; Reisner SA; Lichtenberg GS; Meltzer RS
J Am Coll Cardiol; 1990 Dec; 16(7):1603-7. PubMed ID: 2254545
[TBL] [Abstract][Full Text] [Related]
7. Intravenous perfluoropropane-exposed sonicated dextrose albumin produces myocardial ultrasound contrast that correlates with coronary blood flow.
Porter TR; Xie F; Kilzer K
J Am Soc Echocardiogr; 1995; 8(5 Pt 1):710-8. PubMed ID: 9417215
[TBL] [Abstract][Full Text] [Related]
8. Multifold sonicated dilutions of albumin with fifty percent dextrose improve left ventricular contrast videointensity after intravenous injection in human beings.
Porter TR; Xie F; Anderson JR; Kricsfeld A; D'Sa A
J Am Soc Echocardiogr; 1994; 7(5):465-71. PubMed ID: 7986543
[TBL] [Abstract][Full Text] [Related]
9. The mechanism and clinical implication of improved left ventricular videointensity following intravenous injection of multi-fold dilutions of albumin with dextrose.
Porter TR; Xie F; Kricsfeld A
Int J Card Imaging; 1995 Jun; 11(2):117-25. PubMed ID: 7673759
[TBL] [Abstract][Full Text] [Related]
10. Myocardial contrast enhancement after intravenous injection of sonicated albumin microbubbles: a transesophageal echocardiography dipyridamole study.
Voci P; Bilotta F; Merialdo P; Agati L
J Am Soc Echocardiogr; 1994; 7(4):337-46. PubMed ID: 7917341
[TBL] [Abstract][Full Text] [Related]
11. Reduction in left ventricular cavitary attenuation and improvement in posterior myocardial contrast with higher molecular weight intravenous perfluorocarbon-exposed sonicated dextrose albumin microbubbles.
Porter TR; Xie F; Kricsfeld A; Deligonul U; Kilzer K
J Am Soc Echocardiogr; 1996; 9(4):437-41. PubMed ID: 8827626
[TBL] [Abstract][Full Text] [Related]
12. Visually discernible myocardial echocardiographic contrast after intravenous injection of sonicated dextrose albumin microbubbles containing high molecular weight, less soluble gases.
Porter TR; Xie F
J Am Coll Cardiol; 1995 Feb; 25(2):509-15. PubMed ID: 7829807
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients.
Geny B; Mettauer B; Muan B; Bischoff P; Epailly E; Piquard F; Eisenmann B; Haberey P
J Am Coll Cardiol; 1993 Oct; 22(4):1193-8. PubMed ID: 8409060
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary transit of sonicated albumin microbubbles during controlled mechanical ventilation: a transthoracic echocardiographic study.
Bilotta F; Fiorani L; Lendaro E; Picardo S; La Rosa I; Rosa G; Fedele F
Anesth Analg; 1999 Aug; 89(2):273-7. PubMed ID: 10439729
[TBL] [Abstract][Full Text] [Related]
15. Contrast opacification of left ventricular myocardium following intravenous administration of sonicated albumin microspheres.
Sanders WE; Cheirif J; Desir R; Zoghbi WA; Hoyt BD; Schulz PE; Quiñones MA
Am Heart J; 1991 Dec; 122(6):1660-5. PubMed ID: 1957761
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study on efficacy of myocardial opacification owing to difference of echocardiographic contrast agents].
Suzuki M; Yamaguchi T
Nihon Rinsho; 1998 Apr; 56(4):909-13. PubMed ID: 9577607
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavity.
Leischik R; Beller KD; Erbel R
Basic Res Cardiol; 1996; 91(1):101-9. PubMed ID: 8660247
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular opacification by intravenous contrast echocardiography.
Castini D; Gentile F; Ornaghi M; Mangiarotti E; Garbin M; Ravaglia R; Gioventù M; Mantero A; Corno R; Limido A; Morandi F; Fiorentini C; Pezzano A; Repetto S; Haider T; Morris H; Marelli C
G Ital Cardiol; 1999 Jun; 29(6):620-9. PubMed ID: 10396665
[TBL] [Abstract][Full Text] [Related]
19. Sonicated albumin in exercise echocardiography: technique and feasibility to enhance endocardial visualization.
Yvorchuk KJ; Sochowski RA; Chan KL
J Am Soc Echocardiogr; 1996; 9(4):462-9. PubMed ID: 8827629
[TBL] [Abstract][Full Text] [Related]
20. Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography.
Keller MW; Glasheen W; Kaul S
J Am Soc Echocardiogr; 1989; 2(1):48-52. PubMed ID: 2627424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
